Condition: Familial Mediterranean Fever · MEFV Gene Mutation · Sponsor: Hospices Civils de Lyon
Familial Mediterranean fever (FMF) is the most common auto-inflammatory disease (prevalence: 1-5 / 10,000 inhabitants). It is caused by mutations in the MEFV gene, which encodes variants of the Pyrine inflammasome. Inflammasomes are protein complexes of the innate immunity that produce pro-inflammatory cytokines (interleukin-1β). In vitro, our preliminary results demonstrated that the activation of the inflammatory pyrine (measured by the concentration of interleukin-1β) by kinase inhibitors is significantly increased in FMF patients compared to healthy subjects. Furthermore, a measurement of cell death gave significant results in differentiating the patients from the controls. The performance of this functional has been tested, fast and simple diagnostic test on common mutations and wish to assess its characteristics for MEFV mutations. The investigators hypothesize that this quick and simple functional test can serve as a diagnostic tool for FMF and can quantitatively discriminate against patients with different mutations (genotypes).
This description comes directly from the study's public registry record.
Yvan Jamilloux, MD · 26 73 26 36 · yvan.jamilloux@chu-lyon.fr
Always discuss trial participation with your own doctor first.
| Hôpital Femme-Mère-Enfant | Bron, France | Recruiting |
| CH de Versailles - Hôpital André Mignot | Le Chesnay, France | Not Yet Recruiting |
| Hôpital Edouard Herriot | Lyon, France | Not Yet Recruiting |
| Hôpital de la Croix-Rousse | Lyon, France | Recruiting |
| CHU de Montpellier | Montpellier, France | Not Yet Recruiting |
| Service de Pédiatrie - CHU de Nîmes - Hôpital Carémeau | Nîmes, France | Not Yet Recruiting |
| Hôpital Tenon | Paris, France | Recruiting |
| Hôpital Lyon Sud | Pierre-Bénite, France | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04478409